LOADING
Comparing Merck & Company (MRK) and Coca-Cola Company (KO) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | KO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $354.8B | $370.4B |
| P/E Ratio | 116.0 | 26.1 |
| Forward P/E | 15.3 | 25.3 |
| PEG Ratio | 2.71 | 4.03 |
| EPS | $1.24 | $3.30 |
| Revenue Growth (YoY) | 5.1% | 6.7% |
| Profit Margin | 4.8% | 28.6% |
| Return on Equity | 7.0% | 42.0% |
| Dividend Yield | 2.28% | 2.40% |
| Beta | 0.23 | 0.34 |
| 52-Week High | $156.00 | $91.94 |
| 52-Week Low | $79.67 | $64.14 |
| Volume | -- | -- |
Coca-Cola Company is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Coca-Cola Company offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.